The Vault series

Insight on what matters - so you can transform your business.

HOW TO CONNECT BIOTECH COMPANIES WITH LARGE PHARMA

07 February 2017

James C. Greenwood is President and CEO of the Biotechnology Innovation Organization (BIO) in Washington, D.C., which represents more than 1,200 biotechnology companies, academic institutions, state...

The 10 Most Common Fallacies of Biopharma Partnering

31 January 2017

Today's biotech companies are increasingly recognizing the importance of aligning with strategic partners to advance their drug candidates to market. But how does the small biotech partner...

WHAT'S THE ROLE OF NON-IMMUNO-ONCOLOGY IN AN IMMUNO-ONCOLOGY WORLD?

18 January 2017

An Interview with Jeff Bockman, PhD of Defined Health  Jeff was a panelist in our January 26th 2017 web discussion on non-IO and IO partnering and development. Click to request a video of the web...

THE TOP 5 BIOPHARMA IPOS OF 2016

11 January 2017

2016 was not exactly the year of the IPO. There were fewer overall offerings in 2016 and the total value of the IPO market was far less than the previous year. However, the biopharmaceutical industry...

FOUR ESSENTIAL STEPS FOR EFFECTIVELY PRESENTING YOUR COMPANY OR ASSETT TO POTENTIAL IN-LICENSORS

15 November 2016

Given the rapid pace of innovation in today’s Life Sciences industry,  it has become more important than ever for biotech companies to align themselves with strategic partners in order to advance...

6 Best Practices for Sharing Regulatory Submission Documents with Third Parties

25 October 2016

Whether it's an IND (Investigational New Drug Application), NDA (New Drug Application), ANDA (Abbreviated New Drug Application), BLA (Biologics License Application), or any other type of electronic...

THE 3 MOST IMPORTANT THINGS TO REMEMBER WHEN SHARING DOCUMENTS DURING DUE DILIGENCE

10 October 2016

We sat with Jim McCarthy, who has over 25 years in business development, to talk about tips on when to share documents during due diligence. Jim McCarthy is a Business Development Expert helping...

TOP FIVE QUESTIONS TO ASK BEFORE ANY DEAL

03 October 2016

We sat down with partnership expert Linda Pullan, PhD, of Pullan Consulting, to get her insights on dealmaking in BioPharma. Vault Series: Linda, for the last 10 years, you have been consulting...

SHAREVAULT ANNOUNCES ECTD VIEWER - MAJOR ADVANCEMENT TAILORED FOR BIOPHARMA REGULATORY SUBMISSIONS

19 September 2016

Today, ShareVault is announcing its eCTD Viewer at the 2016 RAPS Regulatory Convergence in San Jose, CA (#2016RAPS, booth 527). ShareVault is the first data room provider to offer integration with an...

BIOPHARMA DEALMAKERS – WHAT'S AN ECTD, AND WHY SHOULD YOU CARE?

13 July 2016

Experienced biopharma dealmakers know that pharma companies seeking to partner with a biotech will require full disclosure of the regulatory submission documents. During due diligence, they will need...

The Seven Habits of Highly Effective Data Rooms

View More

Popular Posts

Stay up to date on the latest industry tips and advice